{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:03:09Z","timestamp":1794016989960,"version":"4.8.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12985-019-1175-z","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T07:11:16Z","timestamp":1558509076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province"],"prefix":"10.1186","volume":"16","author":[{"given":"C.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wj","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qw","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"6","key":"1175_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"9","key":"1175_CR2","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ijc.30238","volume":"139","author":"CE Depuydt","year":"2016","unstructured":"Depuydt CE, Thys S, Beert J, et al. Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer. Int J Cancer. 2016;139(9):2021\u201332.","journal-title":"Int J Cancer"},{"issue":"17","key":"1175_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131(17):2201\u201321.","journal-title":"Clin Sci (Lond)"},{"issue":"9895","key":"1175_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, et al. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399.","journal-title":"Lancet."},{"issue":"2","key":"1175_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1175_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1634\/theoncologist.2014-0303","volume":"20","author":"B Wang","year":"2015","unstructured":"Wang B, He M, Chao A, et al. Cervical Cancer screening among adult women in China, 2010. Oncologist. 2015;20(6):627\u201334.","journal-title":"Oncologist."},{"issue":"4","key":"1175_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370.","journal-title":"Int J Cancer"},{"issue":"9679","key":"1175_CR8","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","volume":"373","author":"N Mu\u00f1oz","year":"2009","unstructured":"Mu\u00f1oz N, Manalastas R, Pitisuttithum P, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet. 2009;373(9679):1949\u201357.","journal-title":"Lancet."},{"issue":"1","key":"1175_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/bjc.2011.185","volume":"105","author":"X Castellsagu\u00e9","year":"2011","unstructured":"Castellsagu\u00e9 X, Mu\u00f1oz N, Pitisuttithum P, et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer. 2011;105(1):28\u201337.","journal-title":"Br J Cancer"},{"issue":"1","key":"1175_CR10","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1038\/s41598-017-13299-y","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X, Xu H, Xu W, et al. Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015. Sci Rep. 2017;7(1):14813.","journal-title":"Sci Rep"},{"issue":"17","key":"1175_CR11","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.7314\/APJCP.2014.15.17.7333","volume":"15","author":"XC Wang","year":"2014","unstructured":"Wang XC, Sun LQ, Ma L, et al. Prevalence and genotype distribution of human papillomavirus among women from Henan, China. Asian Pac J Cancer Prev. 2014;15(17):7333\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"1175_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/jmv.24281","volume":"87","author":"Q Bi","year":"2015","unstructured":"Bi Q, Zhang L, Zhao Z, et al. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China. J Med Virol. 2015;87(12):2114\u201321.","journal-title":"J Med Virol"},{"issue":"6","key":"1175_CR13","doi-asserted-by":"publisher","first-page":"e014135","DOI":"10.1136\/bmjopen-2016-014135","volume":"7","author":"HH Xu","year":"2017","unstructured":"Xu HH, Lin A, Chen YH, et al. Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37\u2009967 women from the general population. BMJ Open. 2017;7(6):e014135.","journal-title":"BMJ Open"},{"issue":"9","key":"1175_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7150\/jca.14971","volume":"7","author":"Z Zeng","year":"2016","unstructured":"Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory. J Cancer. 2016;7(9):1037\u201343.","journal-title":"J Cancer"},{"issue":"4","key":"1175_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cid\/ciw354","volume":"63","author":"SM Garland","year":"2016","unstructured":"Garland SM, Kjaer SK, Mu\u00f1oz N, et al. Impact and effectiveness of the Quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63(4):519\u201327.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1175_CR16","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/IGC.0b013e3181f16c5f","volume":"20","author":"J Ting","year":"2010","unstructured":"Ting J, Kruzikas DT, Smith JS. A global review of age-specific and overall prevalence of cervical lesions. Int J Gynecol Cancer. 2010;20(7):1244\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"4 Suppl","key":"1175_CR17","first-page":"S5","volume":"43","author":"JS Smith","year":"2008","unstructured":"Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 Suppl):S5\u201325 S25.e1-41.","journal-title":"J Adolesc Health"},{"issue":"12","key":"1175_CR18","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1158\/1055-9965.EPI-10-0645","volume":"19","author":"P Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez P, Hildesheim A, Rodr\u00edguez AC, et al. Behavioral\/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomark Prev. 2010;19(12):3044\u201354.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"1175_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/jmv.1085","volume":"64","author":"KH Fife","year":"2001","unstructured":"Fife KH, Cramer HM, Schroeder JM, et al. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol. 2001;64(4):550\u20139.","journal-title":"J Med Virol"},{"issue":"3","key":"1175_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2014.03.552","volume":"133","author":"EL Dickson","year":"2014","unstructured":"Dickson EL, Vogel RI, Geller MA, et al. Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65. Gynecol Oncol. 2014;133(3):405\u20138.","journal-title":"Gynecol Oncol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1175-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:09:04Z","timestamp":1589843344000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1175-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1175"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1175-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by Ethics Committees of Jiangsu Province Hospital of TCM. The Ethical committee approval reference number is 2018NL-052-02.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript do not contain any individual person\u2019s data in any form (including individual details, images or videos.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work. The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"67"}}